@article{article, title  = {{Cabazitaxel for the second-line treatment of metastatic hormone-refractory prostate cancer: a NICE single technology appraisal.}},

 url = {{}},

 year = {{2013}},

 month = {{4}},

 author = {{Kearns B and Lloyd Jones M and Stevenson M and Littlewood C}},

 doi = {{10.1007/s40273-013-0050-9}},

 volume = {{31}},

 journal = {{Pharmacoeconomics}},

 issue = {{6}},

 pages = {{479-488}},

 note = {{Accessed on 2024/10/18}}}